Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Nina Wressnigg, Romana Hochreiter et al.|The Lancet|2023

Cited by 218